Home
About
Overview
Sharing Data
ORCID
Help
History (16)
Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells.
Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer.
Clinical Utility of a Circulating Tumor Cell-Based Cerebrospinal Fluid Assay in the Diagnosis and Molecular Analysis of Leptomeningeal Disease in Patients With Advanced Non-Small Cell Lung Cancer.
HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression.
Regression of ovarian cancer xenografts by depleting or inhibiting RLIP.
See All 16 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Regression of ovarian cancer xenografts by depleting or inhibiting RLIP.
Regression of ovarian cancer xenografts by depleting or inhibiting RLIP. Biochem Pharmacol. 2023 11; 217:115847.
View in:
PubMed
subject areas
Cell Line, Tumor
Cisplatin
Drug Resistance, Neoplasm
Female
Heterografts
Humans
Ovarian Neoplasms
Signal Transduction
authors with profiles
Ravi Salgia